Cumberland Pharmaceuticals Inc (CPIX): Operating Cash Flow
$4.93M
Year ended 2025-12-31
$746.0K
Trailing 12 months to 2026-06-30
-16.4%
3-year compound annual growth
-1.8%
5-year compound annual growth
-1.7%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.93M | n/m | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | -$612.2K | n/m | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $6.09M | -27.9% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $8.45M | +33.3% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $6.34M | +17.1% | 2023-03-13, From 2021-01-01 |
| 2020-12-31 | $5.42M | +77.2% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $3.06M | -1.8% | 2022-03-11, From 2019-01-01 |
| 2018-12-31 | $3.11M | n/m | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | -$557.7K | n/m | 2020-03-20, From 2017-01-01 |
| 2016-12-31 | $569.5K | -90.3% | 2019-03-12, From 2016-01-01 |
| 2015-12-31 | $5.88M | -12.2% | 2018-03-09, From 2015-01-01 |
| 2014-12-31 | $6.69M | +797.1% | 2017-03-13, From 2014-01-01 |
| 2013-12-31 | $746.1K | -89.5% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $7.14M | -18.2% | 2015-03-09, From 2012-01-01 |
| 2011-12-31 | $8.72M | n/m | 2014-03-11, From 2011-01-01 |
| 2010-12-31 | $346.7K | -14.4% | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | $405.0K | n/a | 2012-03-07, From 2009-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $4.93M | n/m |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$52.43M | n/m |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $1.24M | -39.9% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$4.99M | n/m |
| Septerna, Inc. (SEPN) | 2025-12-31 | $110.19M | n/m |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $57.67M | -68.7% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | -$187.49M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$13.36M | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$171.27M | n/m |
Compare CPIX, AQST, INBP, XLO side by side · Screen every company in Pharmaceutical Preparations ↗